BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $42.73 million. The enterprise value is $135.91 million.

Market Cap	42.73M
Enterprise Value	135.91M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BTAI has 19.65 million shares outstanding. The number of shares has increased by 126.53% in one year.

Current Share Class	19.65M
Shares Outstanding	19.65M
Shares Change (YoY)	+126.53%
Shares Change (QoQ)	+62.25%
Owned by Insiders (%)	0.35%
Owned by Institutions (%)	4.83%
Float	18.07M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.08
Forward PS	43.19
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	156.58
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.76

Current Ratio	0.76
Quick Ratio	0.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-68.72%
Return on Invested Capital (ROIC)	-204.90%
Return on Capital Employed (ROCE)	661.03%
Revenue Per Employee	$23,459
Profits Per Employee	-$1.38M
Employee Count	37
Asset Turnover	0.02
Inventory Turnover	1.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.69% in the last 52 weeks. The beta is 0.19, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-77.69%
50-Day Moving Average	3.16
200-Day Moving Average	2.68
Relative Strength Index (RSI)	36.15
Average Volume (20 Days)	1,031,407

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BTAI had revenue of $868,000 and -$50.95 million in losses. Loss per share was -$11.08.

Revenue	868,000
Gross Profit	-1.26M
Operating Income	-50.15M
Pretax Income	-50.95M
Net Income	-50.95M
EBITDA	-49.85M
EBIT	-50.15M
Loss Per Share	-$11.08

Balance Sheet

The company has $17.44 million in cash and $108.94 million in debt, giving a net cash position of -$91.51 million or -$4.66 per share.

Cash & Cash Equivalents	17.44M
Total Debt	108.94M
Net Cash	-91.51M
Net Cash Per Share	-$4.66
Equity (Book Value)	-107.67M
Book Value Per Share	-16.26
Working Capital	-8.13M

Cash Flow

Operating Cash Flow	-55.77M
Capital Expenditures	n/a
Free Cash Flow	-55.77M
FCF Per Share	-$2.84

Margins

Gross Margin	-144.59%
Operating Margin	-5,777.88%
Pretax Margin	-5,869.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-126.53%
Shareholder Yield	-126.53%
Earnings Yield	-114.75%
FCF Yield	-125.59%

Analyst Forecast

The average price target for BTAI is $32.80, which is 1,408.05% higher than the current price. The consensus rating is "Buy".

Price Target	$32.80
Price Target Difference	1,408.05%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	137.17%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	1:16

Scores

BTAI has an Altman Z-Score of -43.41 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-43.41
Piotroski F-Score	1